Seznam kandidatnih snovi, ki vzbujajo veliko zaskrbljenost in za katere je treba pridobiti avtorizacijo
Seznam kandidatnih snovi, ki vzbujajo veliko zaskrbljenost in za katere je treba pridobiti avtorizacijo
Seznam kandidatnih snovi, ki vzbujajo veliko zaskrbljenost in za katere je treba pridobiti avtorizacijo
Filter the list
| Odločba | Nabor podatkov IUCLID | ||||||
|---|---|---|---|---|---|---|---|
|
271-093-5
|
68515-50-4
|
16-jun.-2014
|
Toxic for reproduction (Article 57c) |
 |
Details | ||
|
271-084-6
|
68515-42-4
|
20-jun.-2011
|
Toxic for reproduction (Article 57c) |
|
Details | ||
|
276-158-1
|
71888-89-6
|
20-jun.-2011
|
Toxic for reproduction (Article 57c) |
|
Details | ||
|
with ≥ 0.3% of dihexyl phthalate (EC No. 201-559-5)
|
-
|
-
|
15-jun.-2015
|
Toxic for reproduction (Article 57c) |
|
Details | |
|
202-486-1
|
96-18-4
|
20-jun.-2011
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
|
Details | ||
|
203-794-9
|
110-71-4
|
18-jun.-2012
|
Toxic for reproduction (Article 57c) |
|
Details | ||
|
215-147-8
|
1306-23-6
|
16-dec.-2013
|
Carcinogenic (Article 57a) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
|
Details | ||
|
|
215-146-2
|
1306-19-0
|
20-jun.-2013
|
Carcinogenic (Article 57a) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
|
Details | |
|
233-710-6
|
10325-94-7
|
15-jan.-2018
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
|
Details | ||
|
244-168-5
|
21041-95-2
|
15-jan.-2018
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
|
Details | ||
|
208-168-9
|
513-78-0
|
15-jan.-2018
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
|
Details | ||
|
231-152-8
|
7440-43-9
|
20-jun.-2013
|
Carcinogenic (Article 57a) Specific target organ toxicity after repeated exposure (Article 57(f) - human health) |
|
Details | ||
|
including cis- and trans- stereo isomeric forms and all possible combinations of the isomers
|
-
|
-
|
19-dec.-2012
|
Respiratory sensitising properties (Article 57(f) - human health) |
|
Details | |
|
203-856-5
|
111-30-8
|
08-jul.-2021
|
Respiratory sensitising properties (Article 57(f) - human health) |
|
Details | ||
|
EDA
|
203-468-6
|
107-15-3
|
27-jun.-2018
|
Respiratory sensitising properties (Article 57(f) - human health) |
|
Details | |
|
204-650-8
|
123-77-3
|
19-dec.-2012
|
Respiratory sensitising properties (Article 57(f) - human health) |
|
Details | ||
|
all possible combinations of the cis- and trans-isomers
|
-
|
-
|
19-dec.-2012
|
Respiratory sensitising properties (Article 57(f) - human health) |
|
Details | |
|
trimellitic anhydride; TMA
|
209-008-0
|
552-30-7
|
27-jun.-2018
|
Respiratory sensitising properties (Article 57(f) - human health) |
|
Details | |
|
X4261
|
401-850-9
|
255881-94-8
|
17-jan.-2022
|
PBT (Article 57d) |
|
Details | |
|
and all major diastereoisomers identified
|
-
|
-
|
28-okt.-2008
|
PBT (Article 57d) |
|
Details | |
|
200-268-0
|
56-35-9
|
28-okt.-2008
|
PBT (Article 57d) |
|
Details | ||
|
204-371-1
|
120-12-7
|
28-okt.-2008
|
PBT (Article 57d) |
|
Details | ||
|
232-140-5
|
7789-00-6
|
18-jun.-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
|
Details | ||
|
213-103-2
|
924-42-5
|
10-jun.-2022
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
|
Details | ||
|
200-879-2
|
75-56-9
|
19-dec.-2012
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
|
Details | ||
|
200-589-6
|
64-67-5
|
19-dec.-2012
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
|
Details | ||
|
215-607-8
|
1333-82-0
|
15-dec.-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
|
Details | ||
|
201-173-7
|
79-06-1
|
30-mar.-2010
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
|
Details | ||
|
|
-
|
-
|
19-dec.-2012
|
Carcinogenic (Article 57a) Mutagenic (Article 57b) |
|
Details | |
|
-
|
423-400-0
|
59653-74-6
|
18-jun.-2012
|
Mutagenic (Article 57b) |
|
Details | |
|
219-514-3
|
2451-62-9
|
18-jun.-2012
|
Mutagenic (Article 57b) |
|
Details | ||
|
|
-
|
-
|
16-jan.-2020
|
Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) |
|
Details | |
|
203-615-4
|
108-78-1
|
17-jan.-2023
|
Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) |
|
Details | ||
|
covering any of their individual isomers and combinations thereof
|
-
|
-
|
16-jul.-2019
|
Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) |
|
Details | |
|
204-661-8
|
123-91-1
|
08-jul.-2021
|
Carcinogenic (Article 57a) Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) |
|
Details | ||
|
224-208-8
|
4247-02-3
|
17-jan.-2023
|
Endocrine disrupting properties (Article 57(f) - human health) |
|
Details | ||
|
202-318-7
|
94-26-8
|
25-jun.-2020
|
Endocrine disrupting properties (Article 57(f) - human health) |
|
Details | ||
|
201-025-1
|
77-40-7
|
08-jul.-2021
|
Endocrine disrupting properties (Article 57(f) - environment) Endocrine disrupting properties (Article 57(f) - human health) |
|
Details | ||
|
|
-
|
-
|
17-jan.-2022
|
Endocrine disrupting properties (Article 57(f) - human health) |
|
Details | |
|
|
-
|
-
|
16-jul.-2019
|
Endocrine disrupting properties (Article 57(f) - environment) |
|
Details | |
|
with ≥0.1% w/w 4-heptylphenol, branched and linear (4-HPbl)
|
-
|
-
|
15-jan.-2018
|
Endocrine disrupting properties (Article 57(f) - environment) |
|
Details | |
|
201-280-9
|
80-46-6
|
12-jan.-2017
|
Endocrine disrupting properties (Article 57(f) - environment) |
|
Details | ||
|
202-679-0
|
98-54-4
|
16-jul.-2019
|
Endocrine disrupting properties (Article 57(f) - environment) |
|
Details | ||
|
substances with a linear and/or branched alkyl chain with a carbon number of 9 covalently bound in position 4 to phenol, ethoxylated covering UVCB- and well-defined substances, polymers and homologues, which include any of the individual isomers and/or combinations thereof
|
799-990-1
|
-
|
20-jun.-2013
|
Endocrine disrupting properties (Article 57(f) - environment) |
|
Details | |
|
substances with a linear and/or branched alkyl chain with a carbon number of 9 covalently bound in position 4 to phenol, covering also UVCB- and well-defined substances which include any of the individual isomers or a combination thereof
|
-
|
-
|
19-dec.-2012
|
Endocrine disrupting properties (Article 57(f) - environment) |
|
Details | |
|
substances with a linear and/or branched alkyl chain with a carbon number of 7 covalently bound predominantly in position 4 to phenol, covering also UVCB- and well-defined substances which include any of the individual isomers or a combination thereof
|
-
|
-
|
12-jan.-2017
|
Endocrine disrupting properties (Article 57(f) - environment) |
|
Details | |
|
covering well-defined substances and UVCB substances, polymers and homologues
|
-
|
-
|
19-dec.-2012
|
Endocrine disrupting properties (Article 57(f) - environment) |
|
Details | |
|
205-426-2
|
140-66-9
|
19-dec.-2011
|
Endocrine disrupting properties (Article 57(f) - environment) |
|
Details | ||
|
3-benzylidene camphor; 3-BC
|
239-139-9
|
15087-24-8
|
15-jan.-2019
|
Endocrine disrupting properties (Article 57(f) - environment) |
|
Details | |
|
with ≥ 0.1% of Michler's ketone (EC No. 202-027-5) or Michler's base (EC No. 202-959-2)
|
229-851-8
|
6786-83-0
|
18-jun.-2012
|
Carcinogenic (Article 57a) |
|
Details | |